Author: Carlos

Research peptides come as salts — usually TFA or acetate. Here is how peptide salt forms and net peptide content change the real concentration in your vial.

What is GLP-1? A plain-language guide to the gut hormone behind modern metabolic medicines, from the incretin effect to how DPP-4 and drug engineering work.

Nootropic peptide side effects are a common question, and the honest answer is that the human safety data are thin and uneven. This entry in our side-effects series looks at three “cognitive” research peptides — Semax, Selank and Dihexa — and what the literature does and does not tell us about their tolerability. The pattern…

Peptide solubility — whether a compound dissolves cleanly and which diluent it needs — is one of the most practical questions in handling research material. Most common peptides dissolve readily in bacteriostatic water, but a meaningful minority resist it, turning cloudy or leaving particles. Understanding why that happens, and what to reach for instead, prevents…

IGF-1 side effects, from the approved drug mecasermin to the research analogs LR3, DES and MGF: hypoglycemia, tissue overgrowth, cancer-pathway concerns, and honest evidence gaps.

Subcutaneous vs intramuscular injection explained: the skin layers, needle angle, length and gauge, absorption, sites, and which peptides suit each route.

Bacteriostatic water vs sterile water vs SWFI: the difference is the preservative. Which diluent to use for multi-dose peptide reconstitution, and why.

Peptide half-life is one of the most quoted — and most misunderstood — numbers in the research literature. Half-life is the time it takes for the amount of a compound in circulation to fall by half. It is a measure of how quickly the body clears a molecule, and it quietly determines how a peptide…